Celularity (CELU) EPS (Basic) Growth (5y) (2024 - 2025)
Celularity (CELU) EPS (Basic) Growth (5y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Celularity | 21.36 Mn | 15.19 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.81% |
| Sep 30, 2025 | 56.06% |
| Jun 30, 2025 | 40.70% |
| Mar 31, 2025 | -16.16% |
| Dec 31, 2024 | -21.45% |
| Sep 30, 2024 | -20.73% |
| Jun 30, 2024 | -18.53% |
| Mar 31, 2024 | -476.42% |